Natalizumab Treatment Leads to an Increase in Circulating CXCR3-expressing B Cells
Neurology: Neuroimmunology and NeuroInflammation - United States
doi 10.1212/nxi.0000000000000292
Full Text
Open PDFAbstract
Available in full text
Categories
Date
October 24, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)